Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

ReCross

K-Number: K210431 · 2021-07-15

Decision Date2021-07-15
Product CodeDQY
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

ReCross is a medical device manufactured by Imds Operations B.V.. It received FDA 510(k) clearance on 2021-07-15 under approval number K210431. The device is classified under product code DQY. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the ReCross?

ReCross is a medical device that received FDA 510(k) clearance on 2021-07-15. It is manufactured by Imds Operations B.V.. The 510(k) number is K210431.

When was ReCross approved by the FDA?

ReCross received FDA 510(k) clearance on 2021-07-15, under approval number K210431.

What company makes ReCross?

ReCross is manufactured by Imds Operations B.V..

What is the FDA product code for ReCross?

The FDA product code for ReCross is DQY.

Other Devices by Imds Operations B.V.

View all 7 devices →

Related Devices (Code: DQY)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.